Evaluation of the Sedative Activity of Naringenin: In Vivo Study with Pharmacokinetics and Molecular Docking Insights
Guardado en:
| Publicado en: | ChemistryOpen vol. 14, no. 10 (Oct 1, 2025) |
|---|---|
| Autor principal: | |
| Otros Autores: | , , , , , , , |
| Publicado: |
John Wiley & Sons, Inc.
|
| Materias: | |
| Acceso en línea: | Citation/Abstract Full Text Full Text - PDF |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
MARC
| LEADER | 00000nab a2200000uu 4500 | ||
|---|---|---|---|
| 001 | 3260492070 | ||
| 003 | UK-CbPIL | ||
| 022 | |a 2191-1363 | ||
| 024 | 7 | |a 10.1002/open.202500114 |2 doi | |
| 035 | |a 3260492070 | ||
| 045 | 0 | |b d20251001 | |
| 084 | |a 233130 |2 nlm | ||
| 100 | 1 | |a Bishwas, Dipu |u Department of Pharmacy, Pabna University of Science and Technology, Pabna, Bangladesh | |
| 245 | 1 | |a Evaluation of the Sedative Activity of Naringenin: In Vivo Study with Pharmacokinetics and Molecular Docking Insights | |
| 260 | |b John Wiley & Sons, Inc. |c Oct 1, 2025 | ||
| 513 | |a Journal Article | ||
| 520 | 3 | |a This research is designed to investigate the sedative effects of naringenin (NAR) and diazepam against thiopental sodium‐induced sleeping mice. NAR (5 and 10 mg kg), diazepam (DZP) (2 mg kg), flumazenil (FLN) (0.1 mg kg), and their combinations are administered intraperitoneally to mice. After 30 min, sleep is induced with intraperitoneal thiopental sodium (20 mg kg), and sleep latency and duration are measured. In silico analysis investigates the role of GABA receptors. NAR significantly reduces sleep latency and prolongs sleep duration in a dose‐dependent manner, with the combination of NAR‐10 and DZP‐2 showing a synergistic effect. The combination of the antagonist (FLN) (NAR‐10 and FLN‐0.1) indicates that latency increases and sleep duration decreases compared to NAR‐10 alone. Furthermore, in silico docking studies corroborates these results, demonstrating a significant binding affinity of NAR (−8.3 kcal mol), which is comparable to the standard ligand DZP (−8.7 kcal mol) and FLN (−7.0 kcal mol) for the GABAA (6X3X) receptor, indicating a GABAergic mechanism. Pharmacokinetics and toxicity evaluations confirm NAR's potential as a safe therapeutic agent, with a high LD50 (2000 mg kg) and minimal toxicity. These findings highlight NAR's potential as a GABAergic sedative agent, requiring further research before being used clinically to treat sleep disorders. | |
| 653 | |a Insomnia | ||
| 653 | |a Receptors | ||
| 653 | |a Benzodiazepines | ||
| 653 | |a Neurotoxicity | ||
| 653 | |a Sleep | ||
| 653 | |a Toxicity | ||
| 653 | |a Molecular docking | ||
| 653 | |a Cytotoxicity | ||
| 653 | |a Brain research | ||
| 653 | |a Permeability | ||
| 653 | |a Pharmacology | ||
| 653 | |a Pharmacokinetics | ||
| 653 | |a Synergistic effect | ||
| 653 | |a Ligands | ||
| 653 | |a Cardiotoxicity | ||
| 653 | |a Nervous system | ||
| 653 | |a Biocompatibility | ||
| 653 | |a In vivo methods and tests | ||
| 653 | |a Natural products | ||
| 653 | |a Sodium | ||
| 653 | |a Drug dosages | ||
| 700 | 1 | |a Bhuia, Md. Shimul |u Bioinformatics and Drug Innovation Laboratory, Bioluster Research Center Ltd., Gopalganj, Dhaka, Bangladesh | |
| 700 | 1 | |a Sheikh, Salehin |u Bioinformatics and Drug Innovation Laboratory, Bioluster Research Center Ltd., Gopalganj, Dhaka, Bangladesh | |
| 700 | 1 | |a Alfaifi, Mohammed |u Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia | |
| 700 | 1 | |a Malik, Abdul |u Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia | |
| 700 | 1 | |a Siddiqui, Nikhat J. |u Department of Internal Surgical Nursing, College of Nursing, King Saud University, Riyadh, Saudi Arabia | |
| 700 | 1 | |a Jain, Divya |u Department of Microbiology, School of Applied & Life Sciences, Uttaranchal University, Dehradun, Uttarakhand, India | |
| 700 | 1 | |a Bappi, Mehedi Hasan |u School of Pharmacy, Jeonbuk National University, Jeonju, Republic of Korea | |
| 700 | 1 | |a Islam, Muhammad Torequl |u Bioinformatics and Drug Innovation Laboratory, Bioluster Research Center Ltd., Gopalganj, Dhaka, Bangladesh | |
| 773 | 0 | |t ChemistryOpen |g vol. 14, no. 10 (Oct 1, 2025) | |
| 786 | 0 | |d ProQuest |t Materials Science Database | |
| 856 | 4 | 1 | |3 Citation/Abstract |u https://www.proquest.com/docview/3260492070/abstract/embedded/7BTGNMKEMPT1V9Z2?source=fedsrch |
| 856 | 4 | 0 | |3 Full Text |u https://www.proquest.com/docview/3260492070/fulltext/embedded/7BTGNMKEMPT1V9Z2?source=fedsrch |
| 856 | 4 | 0 | |3 Full Text - PDF |u https://www.proquest.com/docview/3260492070/fulltextPDF/embedded/7BTGNMKEMPT1V9Z2?source=fedsrch |